Author

Bridget Kelly Marcellino

Observed names: B. Marcellino, B.K. Marcellino, Bridget K Marcellino, Bridget K. Marcellino, Bridget Marcellino, Bridget Marcellino,, Marcellino, B.K., Marcellino, Bridget K.

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Observed institutions: Mount Sinai Hospital, Tisch Cancer Institute, Barnard College, Icahn School of Medicine at Mount Sinai

ORCID: 0000-0001-8590-6175

Observed ORCID: 0000-0001-8590-6175

OpenAlex ID: A5024406562

Cell “Self‐Eating” (Autophagy) Mechanism in Alzheimer's Disease

2010 · Sarah F. Funderburk, Bridget K. Marcellino, et al. · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · 145

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53

2018 · Bridget K. Marcellino, Ronald Hoffman, et al. · Blood Advances · 72

Mapping genotypes to chromatin accessibility profiles in single cells

2024 · Franco Izzo, Robert M. Myers, et al. · Nature · 67

The Myelodepletive Phenotype in Myelofibrosis: Clinical Relevance and Therapeutic Implication

2020 · Bridget K. Marcellino, Srdan Verstovsek, et al. · Clinical Lymphoma Myeloma & Leukemia · 57

α-N-Acetylmannosamine (ManNAc) Synthesis via Rhodium(II)-Catalyzed Oxidative Cyclization of Glucal 3-Carbamates

2005 · Rena Bodner, Bridget K. Marcellino, et al. · The Journal of Organic Chemistry · 51

Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies

2021 · Jonathan Feld, Douglas Tremblay, et al. · HemaSphere · 50

Role of the hypothalamus in mediating protective effects of dietary restriction during aging

2012 · Penny A. Dacks, Cesar L. Moreno, et al. · Frontiers in Neuroendocrinology · 38

An MDM2 degrader for treatment of acute leukemias

2022 · Bridget K. Marcellino, Xiaobao Yang, et al. · Leukemia · 36

Eosinophilia in acute myeloid leukemia: Overlooked and underexamined

2019 · Leonard Naymagon, Bridget Marcellino, et al. · Blood Reviews · 36

Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin

2020 · Bridget K. Marcellino, Noushin Farnoud, et al. · Blood Advances · 31

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)

2019 · J. Mascarenhas, B.K. Marcellino, et al. · Leukemia Research · 28

Distinguishing autoimmune myelofibrosis from primary myelofibrosis.

2018 · Bridget Marcellino, Siraj M El Jamal, et al. · PubMed · 26

Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications

2023 · Daniel I. Nathan, Max Dougherty, et al. · Critical Reviews in Oncology/Hematology · 22

Clonal Hematopoiesis of Indeterminate Potential in Crohn’s Disease and Ulcerative Colitis

2025 · Myvizhi Esai Selvan, Daniel I Nathan, et al. · Inflammatory Bowel Diseases · 21

Clinical Course of Cancer Patients With COVID-19: A Retrospective Cohort Study

2020 · Naomi Alpert, Joseph L Rapp, et al. · JNCI Cancer Spectrum · 20

Dietary Restriction and Glycolytic Inhibition Reduce Proteotoxicity and Extend Lifespan via NHR-49.

2018 · Bridget K Marcellino, Nydia Ekasumara, et al. · PubMed · 16

Prevalence of Cytopenia in the General Population—A National Health and Nutrition Examination Survey Analysis

2020 · Naomi Alpert, Joseph L. Rapp, et al. · Frontiers in Oncology · 14

Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19

2020 · Guido Lancman, Bridget K. Marcellino, et al. · Annals of Hematology · 14

Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection

2020 · Fahad Khan, Tayler van den Akker, et al. · Journal of Hematopathology · 14

Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity

2023 · Benjamin O. Adegbite, Matthew H. Abramson, et al. · Clinical Journal of the American Society of Nephrology · 13

JAK inhibitors in the treatment of myelofibrosis.

2022 · Hannah Levavi, Ronald Hoffman, et al. · PubMed · 13

Integrated Single-Cell Genotyping and Chromatin Accessibility Charts JAK2 V617F Human Hematopoietic Differentiation

2022 · Robert M. Myers, Franco Izzo, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 13

Management of advanced phase myeloproliferative neoplasms.

2019 · Bridget Marcellino, John Mascarenhas · PubMed · 11

Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease

2025 · Daniela Guisado, Sayali Talware, et al. · Gut · 9

Recent advances in prognostication and treatment of polycythemia vera

2021 · Bridget K Marcellino, Ronald Hoffman · Faculty Reviews · 9

Works count: 112

Citation count: 942

H-index: 16

I10-index: 23